Search research articles
Contact Us
Filters
Showing results (1-10 of 317) with videos related to
Page
of 32
Sort By:
Neurology
|
March 13, 2002
Language and spatial attention can lateralize to the same hemisphere in healthy humans
Leonidas Stefanis
Cold Spring Harbor Perspectives in Medicine
|
February 23, 2012
α-Synuclein in Parkinson's disease
Leonidas Stefanis
Expert Opinion on Therapeutic Targets
|
April 7, 2012
Targeting intracellular and extracellular alpha-synuclein as a therapeutic strategy in Parkinson's disease and other synucleinopathies
Kostas Vekrellis, Leonidas Stefanis
CNS & Neurological Disorders Drug Targets
|
October 15, 2010
Autophagy in the central nervous system: implications for neurodegenerative disorders
Maria Xilouri, Leonidas Stefanis
Expert Reviews in Molecular Medicine
|
March 23, 2011
Autophagic pathways in Parkinson disease and related disorders
Maria Xilouri, Leonidas Stefanis
Molecular and Cellular Neurosciences
|
March 1, 2015
Chaperone mediated autophagy to the rescue: A new-fangled target for the treatment of neurodegenerative diseases
Maria Xilouri, Leonidas Stefanis
Journal of Parkinson'S Disease
|
November 6, 2025
Inter-relationship of the age of onset to the concept of brain-first versus body-first Parkinson's disease
Leonidas Stefanis, Per Borghammer
Ageing Research Reviews
|
August 4, 2016
Chaperone mediated autophagy in aging: Starve to prosper
Maria Xilouri, Leonidas Stefanis
Advances in Clinical Chemistry
|
September 6, 2023
microRNA and circRNA in Parkinson's Disease and atypical parkinsonian syndromes
Anastasia Bougea, Leonidas Stefanis
Neurochemical Research
|
June 5, 2013
The neurobiology of LRRK2 and its role in the pathogenesis of Parkinson's disease
Hardy J Rideout, Leonidas Stefanis
Page
of 32
Search research articles
Search
Showing results (1-10 of 317) with videos related to
Sort By:
Page
of 32
Neurology
|
March 13, 2002
Language and spatial attention can lateralize to the same hemisphere in healthy humans
Leonidas Stefanis
Cold Spring Harbor Perspectives in Medicine
|
February 23, 2012
α-Synuclein in Parkinson's disease
Leonidas Stefanis
Expert Opinion on Therapeutic Targets
|
April 7, 2012
Targeting intracellular and extracellular alpha-synuclein as a therapeutic strategy in Parkinson's disease and other synucleinopathies
Kostas Vekrellis, Leonidas Stefanis
CNS & Neurological Disorders Drug Targets
|
October 15, 2010
Autophagy in the central nervous system: implications for neurodegenerative disorders
Maria Xilouri, Leonidas Stefanis
Expert Reviews in Molecular Medicine
|
March 23, 2011
Autophagic pathways in Parkinson disease and related disorders
Maria Xilouri, Leonidas Stefanis
Molecular and Cellular Neurosciences
|
March 1, 2015
Chaperone mediated autophagy to the rescue: A new-fangled target for the treatment of neurodegenerative diseases
Maria Xilouri, Leonidas Stefanis
Journal of Parkinson'S Disease
|
November 6, 2025
Inter-relationship of the age of onset to the concept of brain-first versus body-first Parkinson's disease
Leonidas Stefanis, Per Borghammer
Ageing Research Reviews
|
August 4, 2016
Chaperone mediated autophagy in aging: Starve to prosper
Maria Xilouri, Leonidas Stefanis
Advances in Clinical Chemistry
|
September 6, 2023
microRNA and circRNA in Parkinson's Disease and atypical parkinsonian syndromes
Anastasia Bougea, Leonidas Stefanis
Neurochemical Research
|
June 5, 2013
The neurobiology of LRRK2 and its role in the pathogenesis of Parkinson's disease
Hardy J Rideout, Leonidas Stefanis
Page
of 32